Market News & Trends
Domain Therapeutics Launches Specific Purpose Vehicle Kaldi Pharma
Domain Therapeutics recently announced the creation of a Specific Purpose Vehicle (SPV), Kaldi Pharma, for the exclusive development of its A2a/A1 and A2a antagonist programs.…
Bristol-Myers Squibb Signs Exclusive Agreement with Bavarian Nordic
Bavarian Nordic and Bristol-Myers Squibb Company recently announced an agreement that provides Bristol-Myers Squibb an exclusive option to license and commercialize PROSTVAC, Bavarian Nordic's investigational…
Patheon Expands Comprehensive API Services With Major Acquisition
Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, recently announced it has reached a definitive…
Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments
Although lung cancer is the third most prevalent cancer type in the world, there are only 18 drugs in the market for its treatment. Further,…
Victrex Launches Multi-Million Dollar Investment in Technology Innovation
Victrex plc, a UK-based global world leader in high-performance polyaryletherketone (PAEK) polymers is planning to increase its global technology leadership with the construction of a…
New Drug Company to Focus on Treating Unmet Medical Needs Across Broad Therapeutic Areas
Turing Pharmaceuticals AG recently announced its official launch, along with news of three acquisitions for its commercial operations and development pipeline. The company also introduced…
XstalBio Issued US Patent for Stabilization of Therapeutic Proteins
XstalBio Ltd a biologic formulation and drug delivery company recently announced the United States Patent and Trademark Office has issued US Patent, US 8,932,715, covering…
Huntingdon Life Sciences & Harlan Laboratories to Operate Under New Brand & Name
Huntingdon Life Sciences (HLS) and Harlan Laboratories recently announced the two companies will be rebranded to reflect the new integrated management structure that has been…
SGS Expands Biomarker Analysis Services
SGS Life Science Services, the leading pharmaceutical clinical and bioanalytical contract solutions provider, recently announced it has invested in additional modules for its COBAS 6000…
Credence MedSystems' Innovative Companion Safety Syringe System Earns Multiple Industry Awards
Credence MedSystems’ Innovative Companion Safety Syringe System Earns Multiple Industry Awards Credence MedSystems, Inc. recently announced the Credence Companion Safety Syringe System has received a…
PBOA Supports FDA SOS Act
The Pharma & Biopharma Outsourcing Association (PBOA) praises Representatives Lance (R-NJ) and Anna Eshoo (D-CA) for introducing the FDA Safety Over Sequestration Act, or FDA…
Japanese Pharmaceutical Market Value Edging Toward $80 Billion
Japan’s pharmaceutical market value is set to grow at a tepid Compound Annual Growth Rate (CAGR) of 1.3% from $72.8 billion in 2013 to reach…
Novasep Selected to Commercially Biomanufacture Mydicar API
Novasep recently announced it has entered into an agreement with Celladon to supply the drug substance for MYDICAR. The €4.7M deal covers scale-up and prevalidation…
Midatech Pharma Poitive Study Results for OpsiSporin
Midatech Pharma recently announced positive results from a proof-of-concept in vivo study with OpsiSporin, a sustained-release treatment for uveitis. Uveitis is an inflammatory process affecting…
Significant Findings in US NIH's Trial of Pluristem's PLX-R18 Cells for Acute Radiation Syndrome
Pluristem Therapeutics Inc. recently announced the positive results of a recently completed trial conducted by the US National Institutes of Health (NIH) to evaluate PLX-R18…
N-of-One Becomes Oracle Silver Level Partner
N-of-One, Inc. recently announced it has become a Silver Partner in Oracle PartnerNetwork (OPN) Specialized program. By attaining Silver Level membership, N-of-One will benefit from…
Dipexium Pharmaceuticals Announces Successful Completion & Initial Results of Phase I Trial
Dipexium Pharmaceuticals, Inc. recently announced successful completion and initial results of DPX-120, a Phase I skin sensitization trial of Locilex (pexiganan cream 0.8%), the company's…
SGS Announces Amino Acid Analytical Services
SGS Life Science Services recently announced it is now able to offer a full range of analytical methods to identify amino acid impurities within pharmaceutical…
Ball Corporation Confirms Acquisition Terms of Rexam PLC
Ball Corporation and Rexam PLC recently announced the terms of a recommended offer by Ball to acquire all of the outstanding shares of Rexam in…
Aegis Awarded US Patent for Non- Invasive Delivery of Anti-Seizure Drugs
Aegis Therapeutics LLC recently announced it has been awarded US Patent No. 8,927,497 providing broad coverage for non-invasive delivery of anti-seizure drugs via a simple…
